Combination chemotherapy with sintilimab for treatment of a male patient with primary pulmonary choriocarcinoma: a case report and literature review

Primary pulmonary choriocarcinoma (PPC) is an extremely rare malignant cancer in men with no clinical guidelines for the treatment. Cytotoxic chemotherapy has a limited effect on the prognosis of PPC. Recently, immune checkpoint inhibitors (ICIs) have shown promising treatment effectiveness. A liter...

Full description

Bibliographic Details

Published in:	Frontiers in Immunology
Main Authors:	Xiaojing Liang, Guoqing Xu, Jisong Zhang, Li Xu, Liangliang Dong, Xiaoyue Wang, Weidong Han, Enguo Chen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Subjects:	primary pulmonary choriocarcinoma chemotherapy immune checkpoint inhibitors programmed death-ligand 1 human chorionic gonadotropin
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1523316/full